Skip to main content

Table 3 Categories of interventions in the standard of care for COVID-19 (N = 129), shown only for categories that were used in more than one trial

From: Standard of care for COVID-19 in randomized clinical trials registered in trial registries and published in preprint servers and scholarly journals: a cross-sectional study

Categories of interventions

N (%)

Antiviral(s) + Antiparasitic(s)

29 (22)

Antiparasitic(s)

17 (13)

Antiviral(s)

7 (5.4)

Antibiotic(s) + Antiviral(s) + Antiparasitic(s)

5 (3.9)

Antibiotic(s) + Antiparasitic(s)

5 (3.9)

Oxygen

4 (3.1)

Antiviral(s) + Antiparasitic(s) + Immunomodulating agents

3 (2.3)

Antithrombotic(s)/Anticoagulant(s)

3 (2.3)

Antiviral(s) + Immunomodulating agents

2 (1.5)

Antibiotic(s) + Antiparasitic(s) + Oxygen + Antithrombotic(s)/Anticoagulant(s) + Corticosteroid(s)

2 (1.5)

Antiviral(s) + Corticosteroid(s) + Other(s)

2 (1.5)

Other(s)

2 (1.5)

Antibiotic(s) + Antiviral(s)

2 (1.5)

Antiviral(s) + Oxygen + Immunomodulating agents

2 (1.5)

Antibiotic(s) + Antiparasitic(s) + Analgesic(s)/Antipyretic(s)

2 (1.5)